JPRN-UMIN000013764
Not yet recruiting
未知
The preventing treatment of the breast cancer high risk case( the gene mutation positive case ) - The preventing treatment of the breast cancer high risk case
Breast Disease Center, Asahikawa Medical University0 sites100 target enrollmentMay 1, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- The hereditariness breast cancer high risk group
- Sponsor
- Breast Disease Center, Asahikawa Medical University
- Enrollment
- 100
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
It does medical examination, an active treatment from the tenderness to the genetic screening positive case.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •the BRCA gene mutation negative case
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Not Applicable
Clinical Study on Triple Negative Breast Cancer With Chinese MedicineProgression-Free-SurvivalRecurrenceOverall SurvivalNCT03332368Sheng Liu620
Terminated
Not Applicable
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 MutationsBRCA1 MutationBreast CancerNCT00700778Fox Chase Cancer Center2
Completed
Not Applicable
Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and TreatmentsBreast CancerNCT05950685Ifat Klein1,602
Not yet recruiting
Phase 3
The genetic screening to the hereditariness breast cancer high risk groupThe hereditariness breast cancer high risk groupJPRN-UMIN000013763Department of Breast Disease Center, Asahikawa Medical University100
Completed
Not Applicable
Comprehensive Screening for Women at High Genetic Risk for Developing Breast CancerBreast CancerNCT00255060Stanford University100